{"id":11887,"date":"2026-05-27T20:33:00","date_gmt":"2026-05-27T18:33:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=c94ea3c50016e58ebcbeafe3491b130d"},"modified":"2026-05-27T20:33:00","modified_gmt":"2026-05-27T18:33:00","slug":"grce-investors-have-opportunity-to-join-grace-therapeutics-inc-fraud-investigation-with-the-schall-law-firm","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=11887","title":{"rendered":"GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--$GRCE<\/a>--The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grace Therapeutics, Inc. (\u201cGrace\u201d or \u201cthe Company\u201d) (NASDAQ: GRCE<\/a>) for violations of the securities laws.<\/p><\/a><\/a>

The investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. Grace announced on April 23, 2026, that \u201cthe U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Company's New Drug Application (NDA) for GTx-104 for the treatment of patients with aSAH.\" According to the Company, \"the FDA referenced certain items in the Chemistry, Manufacturing, and Controls (CMC) and Non-Clinical sections of the application,\" which \"are related to leachables data for product packaging, non-clinical product toxicology risk assessments, and product manufacturing deficiencies at our contract manufacturing organization.\" Based on this news, shares of Grace fell by nearly 45.5% on the same day.<\/p>

If you are a shareholder who suffered a loss, click here to participate<\/a>.<\/p>

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com<\/a>, or by email at bschall@schallfirm.com<\/a>.<\/p>

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p> Contacts<\/b>

The Schall Law FirmBrian Schall, Esq.310-301-3335info@schallfirm.com<\/a>www.schallfirm.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–$GRCE–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Grace Therapeutics, Inc. (\u201cGrace\u201d or \u201cthe Company\u201d) (NASDAQ: GRCE) for violatio…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-11887","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11887"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11887\/revisions"}],"predecessor-version":[{"id":11888,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/11887\/revisions\/11888"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}